10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,333 | -30.3% | 202 | -5.6% | 0.00% | 0.0% |
| Q2 2023 | $11,950 | +6.0% | 214 | +5.9% | 0.00% | 0.0% |
| Q1 2023 | $11,270 | +67.2% | 202 | +9.2% | 0.00% | 0.0% |
| Q4 2022 | $6,741 | – | 185 | +2212.5% | 0.00% | – |
| Q3 2022 | $0 | – | 8 | -27.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 11 | -68.6% | 0.00% | – |
| Q1 2022 | $3,000 | -72.7% | 35 | -53.3% | 0.00% | -100.0% |
| Q4 2021 | $11,000 | +266.7% | 75 | +275.0% | 0.00% | +100.0% |
| Q3 2021 | $3,000 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,753,528 | $133,391,000 | 100.00% |
| Foresite Capital Management I, LLC | 750,000 | $57,053,000 | 99.71% |
| 12 West Capital Management LP | 2,518,500 | $191,582,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 1,336,253 | $101,649,000 | 9.59% |
| Blue Water Life Science Advisors, LP | 211,917 | $16,121,000 | 7.65% |
| Decheng Capital Management III (Cayman), LLC | 303,984 | $23,124,000 | 7.09% |
| FINANCIAL CONSULATE, INC | 154,942 | $11,786,000 | 4.53% |
| Evolutionary Tree Capital Management, LLC | 54,128 | $4,118,000 | 2.86% |
| HARVARD MANAGEMENT CO INC | 186,143 | $14,160,000 | 1.43% |
| Brown Capital Management | 1,663,469 | $126,540,000 | 1.26% |